Meropenem (MERONEM) IV is indicated for treatment of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: Meropenem (MERONEM) IV: (Adults and children): Lower respiratory tract infections; Urinary tract infections including complicated infections; Intra-abdominal infections; Gynaecological infections including postpartum infections; Skin and skin structure infections; Septicaemia; Meningitis.
Empiric treatment including initial monotherapy for presumed bacterial infections in host-compromised neutropenic patients.
Polymicrobial Infections: because of its broad spectrum of bactericidal activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria, meropenem is effective for the polymicrobial infections.
Intravenous meropenem has been used effectively in patients with cystic fibrosis and chronic lower respiratory tract infections, either as monotherapy or in combination with other antibacterial agents. Eradication of the organism was not always established.
Other Services
Country
Account